🔗 Visit the ClinicalTrials.gov page for NCT01060514
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. | J Cancer | 2013 | 1.31 |
| 2 | Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer. | Curr Cancer Drug Targets | 2012 | 0.86 |
| 3 | Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer. | Onco Targets Ther | 2013 | 0.85 |
| 4 | Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors. | Cancer Med | 2014 | 0.78 |